Aclaris Therapeutis (ACRS) PT Lowered to $34 at JMP Securities
Tweet
Share
E-mailGet Alerts ACRS Hot Sheet
Price: $5.00 +1.83%
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Rating Summary:
14 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 25
Join SI Premium – FREE
JMP Securities analyst Donald Ellis lowered the price target on Aclaris Therapeutis (NASDAQ: ACRS) to $34.00 (from $47.00) while maintaining a Market Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LTIMindtree Ltd (LTIM:IN) PT Lowered to INR3,455 at Citi
- MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs
- Wipro Ltd. (WPRO:IN) (WIT) PT Lowered to INR160 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
